Our technology-enabled service is uniquely optimized for plans seeking to control the high costs of managing complex cardiac, kidney, and metabolic disease patients, while improving clinical outcomes.
Comprehensive remote diagnosis and treatment across the full spectrum of cardiovascular disease: atherosclerosis, valve disease, heart failure, arrhythmia, ...
Diagnosis, GDMT in 8 weeks, volume management. Enrollment, management, detailed reporting.
Rapid titration, control in 6-10 weeks. Enrollment, management, detailed reporting.
Rapid titration of oral and injectables, control in 6-12 weeks. Enrollment, management, detailed reporting.
Cardiac, kidney, and metabolic disease. Prevention of CKD progression. Management of cardiac and metabolic comorbidities. Preparation for dialysis.
Rapid and effective attainment of treatment guidelines.
>90% at goal in 12 weeks or less across most conditions. Challenging quality measures attained
A care model that members love
94 Net Promoter Score. High engagement and adherence.
Reduction in total medical expenditure
Reduced resource utilization via rapid and principled guideline-based care. Software-driven uniformity in quality across provider group.